Similar articles

• Correlation between HSD17B4 expression in rat liver cancer tissues and inflammation or proliferation.

  Pan LC, Xiao HY, Yin WJ, Lin Z. Pan LC, et al. Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3386-3393. doi: 10.26355/eurrev_201806_15160. Eur Rev Med Pharmacol Sci. 2018. PMID: 29917219
• NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.

  Lu X, Ma P, Shi Y, Yao M, Hou L, Zhang P, Jiang L. Lu X, et al. Mol Cell Endocrinol. 2015 Feb 5;401:1-11. doi: 10.1016/j.mce.2014.11.016. Epub 2014 Nov 28. Mol Cell Endocrinol. 2015. PMID: 25448063
• 17β‑hydroxysteroid dehydrogenase 4 induces liver cancer proliferation‑associated genes via STAT3 activation.

  Lu X, Kong L, Wang X, Liu W, Ma P, Jiang L. Lu X, et al. Oncol Rep. 2019 Mar;41(3):2009-2019. doi: 10.3892/or.2019.6981. Epub 2019 Jan 23. Oncol Rep. 2019. PMID: 30747222
• Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome.

  de Launoit Y, Adamski J. de Launoit Y, et al. J Mol Endocrinol. 1999 Jun;22(3):227-40. doi: 10.1677/jme.0.0220227. J Mol Endocrinol. 1999. PMID: 10343282 Review.
• Expression of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) in adipose tissue.

  Labrie F, Simard J, Luu-The V, Trudel C, Martel C, Labrie C, Zhao HF, Rhéaume E, Couet J, Breton N. Labrie F, et al. Int J Obes. 1991 Sep;15 Suppl 2:91-9. Int J Obes. 1991. PMID: 1794945 Review. No abstract available.